We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$630M
AUM Growth
+$19.1M
Cap. Flow
-$22.7M
Cap. Flow %
-3.61%
Top 10 Hldgs %
32.12%
Holding
186
New
13
Increased
53
Reduced
79
Closed
17

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$4.6M
2
LOW icon
Lowe's Companies
LOW
+$4.54M
3
GNRC icon
Generac Holdings
GNRC
+$4.05M
4
ZBH icon
Zimmer Biomet
ZBH
+$3.64M
5
CHWY icon
Chewy
CHWY
+$2.07M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.11M
2
VMW
VMware, Inc
VMW
+$6.88M
3
ACM icon
Aecom
ACM
+$6.65M
4
PFE icon
Pfizer
PFE
+$5.11M
5
BKH icon
Black Hills Corp
BKH
+$4.28M

Sector Composition

Rank Sector Weight
1 Technology 30.19%
2 Healthcare 17.08%
3 Industrials 16.64%
4 Utilities 9.87%
5 Energy 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$35.5M 5.64%
365,202
-11,622
-3% -$1.06M
GLW icon
2
Corning
GLW
$128B
$22.7M 3.6%
744,708
+14,758
+2% +$422K
IBM icon
3
IBM
IBM
$222B
$21.6M 3.42%
131,867
-1,475
-1% -$223K
OGE icon
4
OGE Energy
OGE
$9.45B
$19.8M 3.14%
567,580
-4,508
-0.8% -$156K
BMY icon
5
Bristol-Myers Squibb
BMY
$136B
$18.5M 2.94%
360,781
+5,652
+2% +$297K
CSCO icon
6
Cisco
CSCO
$433B
$18.5M 2.93%
365,866
-7,359
-2% -$376K
NVS icon
7
Novartis
NVS
$292B
$18.3M 2.9%
180,900
-1,790
-1% -$173K
INTC icon
8
Intel
INTC
$473B
$16.1M 2.55%
319,631
-5,215
-2% -$212K
TSM icon
9
TSMC
TSM
$2.17T
$16M 2.53%
153,542
-518
-0.3% -$49.4K
TEL icon
10
TE Connectivity
TEL
$58.7B
$15.6M 2.48%
111,112
+1,082
+1% +$139K
SLB icon
11
SLB Ltd
SLB
$85.1B
$13.8M 2.19%
265,562
-5,750
-2% -$313K
MSFT icon
12
Microsoft
MSFT
$3.81T
$13.2M 2.1%
35,146
+68
+0.2% +$24.2K
AVGO icon
13
Broadcom
AVGO
$1.75T
$13.1M 2.07%
117,150
+48,620
+71% +$4.6M
PFE icon
14
Pfizer
PFE
$159B
$11.7M 1.86%
407,708
-169,128
-29% -$5.11M
AMZN icon
15
Amazon
AMZN
$2.87T
$11.2M 1.78%
73,714
-1,275
-2% -$179K
XOM icon
16
ExxonMobil
XOM
$644B
$10.9M 1.73%
109,047
-770
-0.7% -$80.9K
MRK icon
17
Merck
MRK
$366B
$10.8M 1.71%
98,799
-1,070
-1% -$111K
BCE icon
18
BCE
BCE
$21.9B
$9.66M 1.53%
245,242
-3,286
-1% -$127K
MDU icon
19
MDU Resources
MDU
$4.16B
$8.22M 1.3%
749,284
-4,964
-0.7% -$52.4K
LNN icon
20
Lindsay Corp
LNN
$1.16B
$7.67M 1.22%
59,375
-250
-0.4% -$30.7K
AGX icon
21
Argan
AGX
$5.86B
$7.59M 1.2%
162,129
-1,736
-1% -$79.2K
DIS icon
22
Walt Disney
DIS
$187B
$7.48M 1.19%
82,799
-917
-1% -$80.8K
TMO icon
23
Thermo Fisher Scientific
TMO
$230B
$7.43M 1.18%
14,005
-623
-4% -$302K
JPM icon
24
JPMorgan Chase
JPM
$951B
$7.15M 1.13%
42,018
+164
+0.4% +$24.9K
HON icon
25
Honeywell
HON
$68.9B
$7.05M 1.12%
35,682
-770
-2% -$139K
1
2 3 4 5

Similar funds

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return

John G. Ullman & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, John G. Ullman & Associates held 186 positions worth $630M, up 3.1% from $611M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates withdrew a net $22.7M in Q4 2023, closing 17 positions and reducing 79 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $9.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Lowe's Companies worth $4.98M.

  • John G. Ullman & Associates's largest Q4 2023 buy was Lowe's Companies: 22,375 shares worth $4.98M.
  • John G. Ullman & Associates added most to Broadcom in Q4 2023, an estimated $4.6M increase.
  • John G. Ullman & Associates's biggest Q4 2023 reduction was Aecom, cutting an estimated $6.65M.
  • John G. Ullman & Associates fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $9.11M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $630M portfolio in Q4 2023.
  • John G. Ullman & Associates opened 13 new positions and closed 17 in Q4 2023.
  • John G. Ullman & Associates's portfolio value rose 3.1% quarter-over-quarter to $630M.

Based on John G. Ullman & Associates's 13F filing for Q4 2023, filed 31 Jan 2024.